FDA Drug Application (020686) for LUMENHANCE by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number020686
Product Number001
FormFOR SOLUTION;ORAL
Dosage3.49MG/GM
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLUMENHANCE
Active IngredientMANGANESE CHLORIDE TETRAHYDRATE



Back to FDA Applications sponsored by BRACCO